Detalles de la búsqueda
1.
Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area.
Radiother Oncol;
197: 110324, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735537
2.
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma.
J Natl Cancer Inst;
2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637942
3.
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
Oral Oncol;
151: 106723, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38387261
4.
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Radiother Oncol;
191: 110051, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135184
5.
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma.
iScience;
26(12): 108347, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38125021
6.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med;
21(1): 464, 2023 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012705
7.
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
JAMA;
330(20): 1961-1970, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015220
8.
Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study.
Radiother Oncol;
189: 109939, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806561
9.
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Eur J Cancer;
194: 113336, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801967
10.
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Lancet Reg Health West Pac;
40: 100895, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691885
11.
Eosinophil dynamics during chemo-radiotherapy correlate to clinical outcome in stage â ¡-â £a nasopharyngeal carcinoma patients: Results from a large cohort study.
Radiother Oncol;
188: 109900, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660752
12.
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.
Eur J Cancer;
191: 112965, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37540921
13.
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
Cell Death Dis;
14(8): 513, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563118
14.
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Nat Commun;
14(1): 4893, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580352
15.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol;
24(7): 798-810, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290468
16.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol;
24(6): 611-623, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269842
17.
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Eur Radiol;
33(11): 7952-7966, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314471
18.
High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma.
Am J Hum Genet;
110(7): 1162-1176, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352861
19.
Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma.
Radiother Oncol;
183: 109635, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963444
20.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med;
21(1): 94, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927541